We also conducted a western blot analysis of IL32 expression in PCs derived from three different EGFR‐mutated NSCLC patients, as compared to cancer cell lines, confirming the up‐regulation of IL32 in all PCs (Figure 1F). The gene discussed is IL32; the disease is cancer.